Compounds made from the liver of 3,6-dichloride [3.1.1], such as acetylcholine neuronicotine receptor collocation； pharmacological synthesis； and compounds used to treat or prevent diseases such as Presenil, Alzheimer's disease, schizophrenia, acute or chronic pain.
AKIREDDY SRINIVASA RAO,BHATTI BALWINDER SINGH,HEEMSTRA RONALD JOSEPH,MURTHY SRINIVASA,STRANCHAN JON PAUL,XIA YUNDE
申请号：
CL2012001483
公开号：
CL2012001483A1
申请日:
2012.06.06
申请国别(地区):
CL
年份:
2013
代理人:
摘要：
The present invention relates to compounds that bind to and modulate the activity of neuronal nicotinic acetylcholine receptors, to processes for preparing these compounds, to pharmaceutical compositions containing these compounds, and to methods of using these compounds for treating a wide variety of conditions and disorders, including those associated with dysfunction of the central nervous system (CNS).COMPUESTOS DERIVADOS DE 3,6-DIAZABICICLO[3.1.1]HEPTANOS, COMO LIGANDOS DE RECEPTORES NICOTINICOS NEURONALES DE ACETILCOLINA； COMPOSICION FARMACEUTICA； Y SU USO PARA EL TRATAMIENTO O LA PREVENCION DE DEMENCIA PRESENIL, ALZHEIMER, ESQUIZOFRENIA, DOLOR AGUDO O CRONICO, ENTRE OTRAS ENFERMEDADES.
